For 2021, an increase in the budget of the National Health Insurance Fund (NHIF) by approximately BGN 312 million is planned. Unlike the previous year, this time it is nominal - within 7.2%, for comparison in 2019 - 2020 it was 9.1%. The main items on which these …
More »Replacing medications – why, when and how?
In recent weeks, we have witnessed a heated debate between doctors and master pharmacists about the right and procedure for prescribing medicines for Bulgarian patients. Pharmacists are starting from the point of view that due to the state of emergency, there is a possibility that certain medicines or their analogues will become scarce goods. Here …
More »Healthcare – short-term problems and ideas with long-term effects during a crisis
The COVID-19 epidemic in Bulgaria is developing. Speculation about whether it is in its beginning, middle and end should be left aside, as the main goal at the moment should be to minimize the risk of the widespread spread of the virus. Even now, predictions about its development are …
More »Eagle, cancer and pike of Bulgarian healthcare
IMPORTANT CLARIFICATION: The article was originally published on the website of the newspaper "SEGA". As a result of DEliberate semantic editing, corrections were made to the text WITHOUT being coordinated with the author. Therefore, we are now publishing the original of the article. We believe that the editorial staff of the newspaper "SEGA" owes the necessary apology for the semantic changes that ...
More »Reform to improve access to healthcare in Bulgaria
|Full text of the analysis| The results of the study of the Bulgarian market show the conclusions of previous analyses, such as the one commissioned by the European Commission in 2019, concerning the positive effects of the entry of biosimilar medicines into European markets. In other words, price competition between biosimilar medicines and reference medicines (together and among themselves) allows …
More »Banished medicines
This year's budget for medicines in Bulgaria amounts to 1.2 billion leva, forming a quarter of the total healthcare budget of the National Health Insurance Fund. However, our market still lacks certain medicines that are easily accessible in the European market. The lack of these medicines, as well as the abuses on this market, are mainly due to …
More »TEAM in the media on drug policy, the pension system and the euro
We started 2019 with a strong start – the topic of healthcare is hot again and the EKIP presented a new study: Proposal for a rational drug policy. The author of the analysis, health economist Arkadi Sharkov, was a guest on one of the most watched shows on the domestic airwaves – “Face to Face” on BTV. According to him, for …
More »NHIF – a financial colossus on feet of clay
Uncontrollably growing budget for medicines Over the past few years, the growth in the cost of medicines paid by the NHIF has been between 15-20% on an annual basis. In 2018, the costs reached 1 billion, and the primary reaction of the institutions was the so-called limitation of payment for innovative medicines, entitled "moratorium", which fell ...
More »Three problems facing domestic healthcare
What are the critical points that the healthcare system will face by the end of 2018? Over the past few months, we have witnessed a number of scandals in the healthcare sector and an unceasing whirlpool of ideas, proposals and policies that, after an attempt to be put into practice, are rejected by the system in every possible way and …
More »Press Conference: Progeneric Policy for Lower Drug Costs
In connection with the deepening financial instability of the healthcare sector in Bulgaria, the experts from the EKIP have found a solution to the problem of the continuous increase in the costs of medicines of the NHIF. The analysis used data from the drug group of sartans (medicinal products for the treatment of arterial hypertension) for the period 2005-2016. …
More »
EKIP– Expert Club for Economics and Politics A Different Opinion